Plasma leptin, fatty acids, and tumor necrosis factor-receptor and insulin resistance in children

Nain-Feng Chu1, Jin-Biou Chang, Shih-Ming Shieh

  • 1Department of Community Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC. chuepi@ndmctsgh.edu.tw

Obesity Research
|April 12, 2003
PubMed

Insights

Overweight children show higher insulin and leptin levels, indicating insulin resistance. Plasma leptin, not NEFA or TNFR1, significantly contributes to hyperinsulinemia and insulin resistance in pediatric populations.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Syndrome Research
  • Obesity and Metabolism

Background:

  • Childhood obesity is a growing concern linked to metabolic disturbances.
  • Insulin resistance is a key factor in the development of type 2 diabetes and cardiovascular disease in children.
  • Understanding the role of specific biomarkers like leptin, NEFA, and TNFR1 is crucial for early detection and intervention.

Purpose of the Study:

  • To investigate the impact of plasma leptin, nonesterified fatty acids (NEFAs), and tumor necrosis factor-receptor 1 (TNFR1) on insulin levels and insulin resistance in children.
  • To compare these markers between overweight and normal-weight children.
  • To identify key predictors of hyperinsulinemia and insulin resistance in pediatric subjects.

Main Methods:

  • Radioimmunoassay, enzymatic spectrophotometric methods, and ELISA were used to measure plasma insulin, leptin, NEFA, and TNFR1 levels in 1032 children.
  • Insulin resistance was assessed using the Homeostasis Model Assessment (HOMA) for insulin resistance index (IRI) and a composite insulin-resistance syndrome score (IRS).
  • Multivariate regression analyses were employed to determine associations after adjusting for confounders like BMI.

Main Results:

  • Overweight children exhibited elevated blood pressure, plasma leptin, insulin levels, IRI, and IRS compared to normal-weight peers.
  • Plasma leptin and TNFR1 showed positive correlations with insulin levels, IRI, and IRS.
  • Plasma leptin levels were significantly associated with insulin levels, IRI, and IRS, independent of BMI and other confounders.

Conclusions:

  • Overweight status in children is associated with adverse metabolic profiles, including higher insulin and leptin levels and insulin resistance.
  • Plasma leptin appears to be a more significant factor in the development of hyperinsulinemia and insulin resistance in children than NEFA or TNFR1.
  • These findings highlight the critical role of leptin in pediatric metabolic health and suggest potential targets for intervention.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.